Precision Medicine
The center will use precision genomics to discover, address and treat genetic diseases, many of which affect infants and children and can cause life-long disability.
Azizi Seixas, with the Department of Population Health and the Center for Healthful Behavior Change at NYU School of Medicine, talks about using risk assessment tools to close the health access gap.
The health system's second "big omics data engine," or BODE 2, funded in part by HHS, will have 15 terabytes of memory, 14 petabytes of raw storage and a peak speed of 220 teraflops per second – nearly double that of its predecessor.
Speaking from experience, Bradford Power, founder of Reengineering Cancer Treatment and an author focused on process improvement, discusses the ways oncology treatment needs to become more personalized.
Dr. Annette Sobel, professor at Texas Tech University and board member at the Translational Research Institute for Space Health, talks about the research of human physiology and human factors in space medicine.
Genomic medicine researchers at the laboratory have been using artificial intelligence, developed as part of Microsoft's Project Hanover, to help manage the vast amount of research data needed to power its precision oncology initiatives.
More than 30% of the health system’s employees have signed up for a precision medicine program that helps get predictive genomics data straight to frontline caregivers.
Erin Trimble of 23andMe discusses the value of polygenic risk scores, making genetic information actionable for better health and equipping primary care providers to talk with their patients about genetics.
DayTwo's metagenomics and gut microbiome database helps connect diabetics and others with evidence-based "food-as-medicine" treatment regimens, says President Josh Stevens.
By enabling board members to review clinical trial treatment options virtually, assessment time can be reduced from 14 days to four, according to a new study in the Journal of the American Medical Informatics Association.